Manuscripts
Showing 1554 manuscripts.
Raltegravir In Vitro Effect on Bilirubin Binding
Citation
Raltegravir In Vitro Effect on Bilirubin Binding. Pediaric Infectious Disease Journal. 2013. 32: 978-980. PMID: 23470680Year
2013
Journal
Pediaric Infectious Disease Journal
Study
P1097
Loss to follow-up among infants in a study of isoniazid prophylaxis (P1041) in South Africa
Citation
S Nachman, M Van der Linde, E Pillay, S Dittmer, S Kim, P Jean-Philippe, J Coetzee, R Bobat, E Hawkins, A Violari, P1041 Team, CA Beneri, B Zeldow. Loss to follow-up among infants in a study of isoniazid prophylaxis (P1041) in South Africa. International Journal of Tuberculosis and Lung Disease. 2013. 17: 32-38. PMID: 23232002Year
2013
Journal
International Journal of Tuberculosis and Lung Disease
Study
P1041
Social Ecological Predictors of Longitudinal Pediatric HIV Treatment Adherence
Citation
Social Ecological Predictors of Longitudinal Pediatric HIV Treatment Adherence. Journal of Pediatric Psychology. 2013. 38: 664-74. PMID: 23629146Year
2013
Journal
Journal of Pediatric Psychology
Study
P1042S
Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth
Citation
PM Flynn, P Muresan, T Fenton, CK Cunningham, W Borkowsky, JB McAuley, SA Spector, E Petzold, W Levy, GK Siberry, E Handelsman, LJ Utech, A Weinberg, RF Pass, S Nachman. Immunogenicity of Licensed Influenza A (H1N1) 2009 Monovalent Vaccines in HIV-Infected Children and Youth. 2013. 2: 352-360. PMID: 24363932Year
2013
Study
P1089
Age-Related Differences in Plasma and Intracellular Tenofovir Concentrations in HIV-1 Infected children, adolescents and adults.
Citation
Edward P. Acosta, Courtney V. Fletcher, Gautam Baheti, Jennifer R. King. Age-Related Differences in Plasma and Intracellular Tenofovir Concentrations in HIV-1 Infected children, adolescents and adults.. AIDS. 2013. 27: 221-225. PMID: 23032419Year
2013
Journal
AIDS
Study
P1058A
Feasibility and Safety of ALVAC-HIV vCP1521 Vaccine in HIV- exposed Infants in Uganda: Results from the First HIV Vaccine Trial in Infants in Africa
Citation
Feasibility and Safety of ALVAC-HIV vCP1521 Vaccine in HIV- exposed Infants in Uganda: Results from the First HIV Vaccine Trial in Infants in Africa. Journal of Acquired Immune Deficiency Syndromes. 2013. 63: 1-8. PMID: 23221981Year
2013
Journal
Journal of Acquired Immune Deficiency Syndromes
Genetic Variants in Toll-Like Receptor 2 (TLR2), TLR4, TLR9, and FC¿ Receptor II Are Associated with Antibody Response to Quadrivalent Meningococcal Conjugate Vaccine in HIV-Infected Youth
Citation
Genetic Variants in Toll-Like Receptor 2 (TLR2), TLR4, TLR9, and FC¿ Receptor II Are Associated with Antibody Response to Quadrivalent Meningococcal Conjugate Vaccine in HIV-Infected Youth. Clinical and Vaccine Immunology. 2013. 20: 900-6. PMID: 23595505Year
2013
Journal
Clinical and Vaccine Immunology
Study
P1065
Ethical tradeoffs in trial design: Case study of an HPV vaccine trial in HIV-infected adolescent girls in lower income settings
Citation
Ethical tradeoffs in trial design: Case study of an HPV vaccine trial in HIV-infected adolescent girls in lower income settings. Developmental Pharmacology and Therapeutics. 2013. 13: 95-104. PMID: 23725055Year
2013
Journal
Developmental Pharmacology and Therapeutics
Genetic Variants in the Host Restriction Factor APOBEC3G are Associated with HIV-1 Related Disease Progression and Central
Citation
Genetic Variants in the Host Restriction Factor APOBEC3G are Associated with HIV-1 Related Disease Progression and Central. Journal of Acquired Immune Deficiency Syndromes. 2013. 62: 197-203. PMID: 23138837Year
2013
Journal
Journal of Acquired Immune Deficiency Syndromes